Methotrexate Suppliers & Bulk Manufacturers

Available Forms: Oral tablets, Injection (IV and IM)

Available Strengths: Tablets: 2.5 mg, 5 mg, 10 mg, 15 mg; IV/IM: 25 mg/mL

Reference Brands: Trexall®, Rheumatrex® (EU & US)

Category: Oncology Cancer Care

Methotrexate is available in Oral tablets, Injection (IV and IM) and strengths such as Tablets: 2.5 mg, 5 mg, 10 mg, 15 mg; IV/IM: 25 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Methotrexate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Methotrexate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Methotrexate, marketed under brand names like Trexall® and Rheumatrex®, is an essential chemotherapy drug and immunosuppressant used in the treatment of various oncologic conditions such as leukemia, lymphoma, breast cancer, and osteosarcoma. Available in oral and injectable forms, with strengths ranging from 2.5 mg to 25 mg/mL, Methotrexate is sourced globally by B2B pharmaceutical suppliers. It is GMP-compliant, ensuring consistent quality for hospitals and oncology centers. Methotrexate's wide availability in the US and EU supports effective cancer care at competitive pricing, making it a trusted option for treating aggressive cancers and autoimmune disorders.